Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-01-16 | 2019-07-26 |
| Drug Identification Number | 02141019 | 02141019 |
| Brand name | CALCIUM GLUCONATE INJECTION, USP 10% | CALCIUM GLUCONATE INJECTION, USP 10% |
| Common or Proper name | Calcium Gluconate | Calcium Gluconate |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | CALCIUM GLUCONATE | CALCIUM GLUCONATE |
| Strength(s) | 94MG | 94MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 50mL | 50mL |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2019-07-26 | 2019-07-26 |
| Estimated end date | 2019-10-08 | 2019-09-30 |
| Actual end date | 2019-10-07 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Product available | 10mL and 50mL vials available for substitution. |
| Health Canada comments |